Comprehensive Hospital-Wide Multidisciplinary Blood Glucose Management Model Officially Launched with Support from Sanofi
Apr 27, 2021 18:18
CST Updated
18:18
Sanofi
Pharmaceutical R&D Developer
On April 26, 2021, the Consensus Release Conference on Hospital-Wide Glycemic Management, hosted by the Hospital Management Institute of Fudan University and supported by Sanofi China, together with the Kick-off Meeting for the 2021 Research and Practice Project on “Multidisciplinary Comprehensive Management of Hospital-Wide Glycemia,” was held in Shanghai. At the meeting, the first research report in China to analyze the multidisciplinary comprehensive management model for hospital-wide glycemia from a hospital management perspective (hereinafter referred to as the “Research Report”) was officially released.
Professor Gao Jiechun, Director of the Institute of Hospital Management at Fudan University and Project Leader; Professor Gao Xin from Zhongshan Hospital Affiliated to Fudan University; Professor Zhao Rong, Director of the Medical Affairs Department at Shanghai Shenkang Hospital Development Center and Project Expert; along with nearly 100 representatives from over 30 representative hospitals, attended the event in person. More than 2,000 hospital administrators and clinical experts across China participated via live online streaming, sharing and exchanging insights on the practice and exploration of a multidisciplinary comprehensive management model for whole-hospital blood glucose control.
Consensus Launch Conference on Hospital-Wide Glucose Management and the 2021 Project Kick-off Meeting
(From left to right: Professor Peng Shuyou, The Second Affiliated Hospital of Zhejiang University School of Medicine; Mr. Zhang Wei, Deputy President, Shenzhen People’s Hospital; Professor Gao Xin, Zhongshan Hospital Fudan University; Professor Gao Jiechun, Director, Institute of Hospital Management, Fudan University; Minister Ren Qian, PLA Army Medical Center; Ms. Qiu Youping, General Manager, Diabetes Division, Sanofi China)
As a research outcome of the first phase of the “Research and Practice Project on Multidisciplinary Comprehensive Management of Hospital-Wide Blood Glucose,” the Research Report proposes the first domestically developed recommended model for multidisciplinary comprehensive management of hospital-wide blood glucose, analyzed and constructed from the perspective of hospital management, based on the research conducted by the initial 16 pilot hospitals.
Professor Gao Jiechun stated, “Since the project’s launch last September, we have conducted multiple rounds of research, surveys, and in-hospital practice through the joint efforts of the project team’s experts and the specialists and physicians at the pilot hospitals. The release of this Research Report marks a significant step forward. In 2021, building on the consensus already achieved through this study, we will undertake activities such as touring lectures and forums, thematic project development meetings, and validation of practical outcomes to verify the implementation of this model nationwide, thereby establishing standardized guidelines with clear comprehensive management effects and broad operational feasibility. By adopting a scientific, rational, and feasible hospital-wide blood glucose management model, we can ensure that patients with abnormal blood glucose levels scattered throughout the hospital receive standardized and timely treatment, while simultaneously freeing up valuable medical resources for the care of patients with complex, critical, and severe conditions. Through the exploration of in-hospital blood glucose management models, we aim to provide reference pathways for high-quality, efficient, and advanced chronic disease management. Furthermore, the widespread promotion and further implementation of this ‘system innovation, technological innovation, and management innovation’ model will serve as a robust practice in advancing the high-quality development of hospitals.”
Professor Gao Xin stated, “Regardless of whether they have diabetes, hospitalized patients may experience abnormalities in glucose metabolism during the treatment of other conditions. If healthcare providers fail to promptly detect and manage patients’ blood glucose levels, such abnormalities can adversely affect the therapeutic outcomes of the primary disease, imposing additional burdens and risks on patients. Therefore, it is crucial to establish a standardized and normalized in-hospital glycemic management model.”
Following the completion of research at the first batch of 16 pilot hospitals in 2020, the project will expand its scope this year by inviting 200 provincial and municipal Tier II Grade A (or higher) hospitals across China to participate in establishing a hospital-wide, multidisciplinary comprehensive management model for blood glucose. Currently, 200 hospitals have registered to participate.
Dr. He Enting, President of Sanofi Greater China, stated, “With nearly a century of experience in diabetes management, Sanofi is committed to continuously launching innovative healthcare solutions to help improve the quality of life for patients in China. We are also dedicated to collaborating with partners to drive further innovation and support the entire landscape of diabetes management in China. The research and practice project on ‘Multidisciplinary Comprehensive Management of Hospital-Wide Glycemia’ demonstrates our firm resolve to work alongside partners in the Chinese medical community to continuously explore innovative solutions that address unmet needs. Looking ahead, we will continue to actively collaborate with all stakeholders to jointly create new opportunities in diabetes management that truly meet the needs of China.”
Consensus Launch Conference on Hospital-Wide Glucose Management and the 2021 Project Kick-off Meeting
(From left to right: Professor Peng Shuyou, The Second Affiliated Hospital of Zhejiang University School of Medicine; Mr. Zhang Wei, Deputy President, Shenzhen People’s Hospital; Professor Gao Xin, Zhongshan Hospital Fudan University; Professor Gao Jiechun, Director, Institute of Hospital Management, Fudan University; Minister Ren Qian, PLA Army Medical Center; Ms. Qiu Youping, General Manager, Diabetes Division, Sanofi China)
As a research outcome of the first phase of the “Research and Practice Project on Multidisciplinary Comprehensive Management of Hospital-Wide Blood Glucose,” the Research Report proposes the first domestically developed recommended model for multidisciplinary comprehensive management of hospital-wide blood glucose, analyzed and constructed from the perspective of hospital management, based on the research conducted by the initial 16 pilot hospitals.
Professor Gao Jiechun stated, “Since the project’s launch last September, we have conducted multiple rounds of research, surveys, and in-hospital practice through the joint efforts of the project team’s experts and the specialists and physicians at the pilot hospitals. The release of this Research Report marks a significant step forward. In 2021, building on the consensus already achieved through this study, we will undertake activities such as touring lectures and forums, thematic project development meetings, and validation of practical outcomes to verify the implementation of this model nationwide, thereby establishing standardized guidelines with clear comprehensive management effects and broad operational feasibility. By adopting a scientific, rational, and feasible hospital-wide blood glucose management model, we can ensure that patients with abnormal blood glucose levels scattered throughout the hospital receive standardized and timely treatment, while simultaneously freeing up valuable medical resources for the care of patients with complex, critical, and severe conditions. Through the exploration of in-hospital blood glucose management models, we aim to provide reference pathways for high-quality, efficient, and advanced chronic disease management. Furthermore, the widespread promotion and further implementation of this ‘system innovation, technological innovation, and management innovation’ model will serve as a robust practice in advancing the high-quality development of hospitals.”
In recent years, with the rising incidence of diabetes and prediabetes, the number of patients with abnormal blood glucose in non-endocrinology departments in China has been increasing year by year. Data show that abnormal blood glucose has a significant impact on the clinical prognosis of hospitalized patients. Taking hyperglycemia as an example, the incidence of complications in diabetic and hyperglycemic surgical patients is four times that of patients with normal blood glucose, and the mortality rate of hyperglycemic patients is 2 to 6 times higher than that of non-hyperglycemic patients. Meanwhile, hyperglycemia also prolongs hospital stays, thereby increasing hospitalization costs and exacerbating the financial burden on patients.
Professor Gao Xin stated, “Regardless of whether they have diabetes, hospitalized patients may experience abnormalities in glucose metabolism during the treatment of other conditions. If healthcare providers fail to promptly detect and manage patients’ blood glucose levels, such abnormalities can adversely affect the therapeutic outcomes of the primary disease, imposing additional burdens and risks on patients. Therefore, it is crucial to establish a standardized and normalized in-hospital glycemic management model.”
Following the completion of research at the first batch of 16 pilot hospitals in 2020, the project will expand its scope this year by inviting 200 provincial and municipal Tier II Grade A (or higher) hospitals across China to participate in establishing a hospital-wide, multidisciplinary comprehensive management model for blood glucose. Currently, 200 hospitals have registered to participate.
Dr. He Enting, President of Sanofi Greater China, stated, “With nearly a century of experience in diabetes management, Sanofi is committed to continuously launching innovative healthcare solutions to help improve the quality of life for patients in China. We are also dedicated to collaborating with partners to drive further innovation and support the entire landscape of diabetes management in China. The research and practice project on ‘Multidisciplinary Comprehensive Management of Hospital-Wide Glycemia’ demonstrates our firm resolve to work alongside partners in the Chinese medical community to continuously explore innovative solutions that address unmet needs. Looking ahead, we will continue to actively collaborate with all stakeholders to jointly create new opportunities in diabetes management that truly meet the needs of China.”